Table 2 Hazard ratios of mortality according to baseline variables among MSM patients diagnosed with AIDS in Brazil, 1998–2008

Age (per 10 year increase)

1.13*

(1.11 - 1.16)

1. 13*

(1.11 - 1.16)

Race**

  White

Reference

Reference

  Non-white

1.15*

(1.09 - 1.21)

1.29*

(1.22 - 1.37)

  Unspecified

0.89*

(0.84 - 0.94)

1.02

(0.96 - 1.08)

Period of diagnosis^t

  1998-2001

Reference

Reference

  2002-2005

0.54*

(0.51 - 0.57)

0.55*

(0.52 - 0.58)

  2006-2008

0.51*

(0.48 - 0.55)

0.52*

(0.49 - 0.56)

CD4 cell count at diagnosis (cells/mm³)

  < 200

Reference

Reference

  200 - 350

0.65*

(0.63 - 0.68)

0.67*

(0.65 - 0.70)

  >350

0.20*

(0.18 - 0.21)

0.19*

(0.17 - 0.20)

HIV-1 RNA (log₁₀ copies)

  <4.00

Reference

Reference

  4.00-5.00

1.28*

(1.19 - 1.37)

1.22*

(1.14 - 1.31)

  >5.00

4.68*

(4.40 - 4.98)

5.26*

(4.94 - 5.61)

Estimated frailty variance

---

0.099*